Related Experiment Videos

Usefulness of [18F]fluorodeoxyglucose positron emission tomography in pediatric epilepsy surgery

O C Snead1, L S Chen, W G Mitchell

  • 1Department of Neurology, University of Southern California School of Medicine, Los Angeles, USA.

Pediatric Neurology
|February 1, 1996
PubMed

Insights

[18F]fluorodeoxyglucose positron emission tomography (FDG-PET) is not a reliable substitute for chronic invasive intracranial monitoring in pediatric epilepsy surgery evaluations. Concordance with electrocorticography is limited, and normal scans do not exclude surgical candidacy.

Area of Science:

  • Neurology
  • Neurosurgery
  • Nuclear Medicine

Background:

  • Pediatric epilepsy surgery requires precise localization of the epileptogenic zone.
  • Interictal [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) is a non-invasive imaging technique used in epilepsy evaluation.
  • Chronic invasive intracranial monitoring provides detailed electrophysiologic data but is invasive.

Purpose of the Study:

  • To compare the utility of FDG-PET with chronic invasive intracranial monitoring in pediatric epilepsy surgery.
  • To determine if FDG-PET can replace or guide the need for invasive monitoring.

Main Methods:

  • Retrospective analysis of 100 pediatric epilepsy surgery patients over 4 years.
  • Comparison of patients who underwent interictal FDG-PET versus those who did not.
  • Correlation of FDG-PET findings with ictal electrocorticography (ECoG) in a subset of patients.

Main Results:

  • No significant differences in surgical rates, procedure types, monitoring use, or outcomes between FDG-PET and no-FDG-PET groups.
  • Limited concordance (2/13 patients) between FDG-PET hypometabolism and the epileptogenic zone identified by ictal ECoG.
  • FDG-PET was normal in some patients with identified epileptogenic foci.

Conclusions:

  • Interictal FDG-PET is not sufficient to exclude children from epilepsy surgery consideration.
  • The correlation between FDG-PET findings and the epileptogenic zone is insufficient to forgo chronic invasive intracranial monitoring.
  • Absolute concordance across all neuroimaging, clinical, and EEG data is necessary before considering skipping invasive monitoring.

Related Concept Videos